BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2025 8:37:57 AM | Browse: 227 | Download: 227
 |
Received |
|
2025-03-10 05:57 |
|
Peer-Review Started |
|
2025-03-10 05:57 |
|
First Decision by Editorial Office Director |
|
2025-03-19 05:55 |
|
Return for Revision |
|
2025-03-19 05:55 |
|
Revised |
|
2025-04-01 18:03 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-07-28 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-28 07:52 |
|
Articles in Press |
|
2025-07-28 07:52 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-02 02:46 |
|
Publish the Manuscript Online |
|
2025-09-15 08:37 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Status quo of hypercoagulation as a prognostic indicator following neoadjuvant immunochemotherapy in locally advanced gastric cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Grigorios Christodoulidis, Dimitra Bartzi, Kyriaki Tsagkidou, Konstantinos Eleftherios Koumarelas and Dimitrios Zacharoulis |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Grigorios Christodoulidis, MD, PhD, Department of General Surgery, University Hospital of Larissa, Mezourlo, Larissa 41110, Thessalia, Greece. gregsurg@yahoo.gr |
| Key Words |
Indicator; Hypercoagulation; Biomarker; Gastric cancer; Immunochemotherapy |
| Core Tip |
The core message of the review emphasizes that hypercoagulation, observed after neoadjuvant immunochemotherapy in patients with locally advanced gastric cancer, serves as a significant independent prognostic indicator. Elevated coagulation markers such as D-dimer and fibrinogen are associated with poorer overall and disease-free survival rates. The article suggests that monitoring these coagulation parameters can enhance patient management by identifying high-risk individuals and tailoring postoperative care accordingly. |
| Publish Date |
2025-09-15 08:37 |
| Citation |
Christodoulidis G, Bartzi D, Tsagkidou K, Koumarelas KE, Zacharoulis D. Status quo of hypercoagulation as a prognostic indicator following neoadjuvant immunochemotherapy in locally advanced gastric cancer. World J Gastrointest Oncol 2025; 17(9): 106868 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i9/106868.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i9.106868 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
